Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2007-11-30
2008-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usage of the Home Macular Perimeter (HMP)
NCT00596388
Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)
NCT00603850
Sensitivity and Specificity of the Home Macular Perimeter (HMP)
NCT00595998
Sensitivity of the Home Macular Perimeter (HMP)
NCT00604071
Age-Related Macular Degeneration (AMD) - Usability Study
NCT00963339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Receive a packed HMP device.
* Unpack the device and install it, using a set-up guide
* Use an interactive tutorial to learn the task
* Calibrate the sensitivity of the test
This stage will be completed within 1 to 5 visits, depending on personal progress rate.
Subjects who have successfully completed stage I will be recruited to stage II.
Those subjects will:
• Perform 3 tests , each test in a different day
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Familiar with computer usage
* Capable and willing to sign a consent form and participate in the study
* Ability to speak, read and understand instructions in English
Exclusion Criteria
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Notal Vision Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Mr Weinstein, MD
Role: PRINCIPAL_INVESTIGATOR
Kidney Health Center of Maryland
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WIRB Pr. No.: 20071980
Identifier Type: -
Identifier Source: secondary_id
T3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.